Simon J A, Solkowitz S N, Carmody T P, Browner W S
General Internal Medicine Section, Department of Veterans Affairs Medical Center, San Francisco, Calif, USA.
Arch Intern Med. 1997 Jun 23;157(12):1371-6.
Cigarette smoking is the greatest cause of preventable mortality in the United States. Because most smokers would like to quit and most hospitals are smoke free, surgical admissions represent a window of opportunity for tobacco cessation interventions.
A total of 324 patients (98% men), aged 25 to 82 years, who were current smokers and who underwent noncardiac surgery were enrolled in a randomized controlled trial at the Veterans Affairs Medical Center, San Francisco, Calif. One hundred sixty-eight participants (52%) received a multicomponent intervention designed to increase self-efficacy and coping skills that included face-to-face in-hospital counseling, viewing a smoking cessation videotape, self-help literature, nicotine replacement therapy, and 3 months of telephone follow-up. One hundred fifty-six participants (48%) received self-help literature and brief counseling lasting 10 minutes. Serum or saliva cotinine levels were measured to confirm self-reported smoking cessation.
At 12 months of follow-up, the self-reported quit rate was 27% among the intervention group and 13% among the comparison group (relative risk, 2.1; 95% confidence interval, 1.2-3.5; P < .01). Based on biochemical confirmation, 15% of the intervention group, compared with 8% of the comparison group, quit smoking at 12 months (relative risk, 2.0; 95% confidence interval, 1.0-3.9; P = .04).
A smoking cessation intervention targeted at smokers hospitalized for noncardiac surgery can increase long-term quit rates. Surgical hospitalizations provide an opportunity to reach smokers who want to quit smoking.
在美国,吸烟是可预防死亡的最大原因。由于大多数吸烟者想要戒烟,且大多数医院都禁止吸烟,手术入院为戒烟干预提供了一个机会窗口。
共有324名年龄在25至82岁之间的现吸烟者,他们接受了非心脏手术,并在加利福尼亚州旧金山的退伍军人事务医疗中心参加了一项随机对照试验。168名参与者(52%)接受了旨在提高自我效能和应对技能的多成分干预,包括在医院进行面对面咨询、观看戒烟录像带、自助文献、尼古丁替代疗法以及3个月的电话随访。156名参与者(48%)接受了自助文献和持续10分钟的简短咨询。测量血清或唾液中的可替宁水平以确认自我报告的戒烟情况。
在12个月的随访中,干预组自我报告的戒烟率为27%,对照组为13%(相对风险,2.1;95%置信区间,1.2 - 3.5;P <.01)。基于生化确认,干预组15%的人在12个月时戒烟,而对照组为8%(相对风险,2.0;95%置信区间,1.0 - 3.9;P =.04)。
针对因非心脏手术住院的吸烟者的戒烟干预可以提高长期戒烟率。手术住院为接触想要戒烟的吸烟者提供了一个机会。